Journal
DRUG DELIVERY
Volume 24, Issue 1, Pages 83-91Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/10717544.2016.1230903
Keywords
Red blood cell; leukocyte; stem cell; carrier; nanoparticle
Categories
Funding
- National Natural Science Foundation of China [81361140344]
- National Basic Research Program of China [2013CB932500]
Ask authors/readers for more resources
Cell-mediated drug delivery systems employ specific cells as drug vehicles to deliver drugs to targeted sites. Therapeutics or imaging agents are loaded into these cells and then released in diseased sites. These specific cells mainly include red blood cells, leukocytes, stem cells and so on. The cell acts as a Trojan horse to transfer the drug from circulating blood to the diseased tissue. In such a system, these cells keep their original properties, which allow them to mimic the migration behavior of specific cells to carry drug to the targeted site after in vivo administration. This strategy elegantly combines the advantages of both carriers, i.e. the adjustability of nanoparticles (NPs) and the natural functions of active cells, which therefore provides a new perspective to challenge current obstacles in drug delivery. This review will describe a fundamental understanding of these cell-based drug delivery systems, and discuss the great potential of combinational application of cell carrier and NPs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available